Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19)...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0dea6c10186f428eb2dce132e7933820 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:0dea6c10186f428eb2dce132e7933820 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:0dea6c10186f428eb2dce132e79338202021-11-17T14:21:58ZEpidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history2150-55942150-560810.1080/21505594.2020.1802870https://doaj.org/article/0dea6c10186f428eb2dce132e79338202020-12-01T00:00:00Zhttp://dx.doi.org/10.1080/21505594.2020.1802870https://doaj.org/toc/2150-5594https://doaj.org/toc/2150-5608Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19) inpatients who contracted SARS-CoV-2 in Wuhan (15 cases), exposed to the patients from Wuhan (26 cases), or acquired the disease without exposure to Wuhan patients (21 cases). Median incubation periods are 4.5 days (3–5) for Wuhan patients, 8 days (3–11) for those infected by Wuhan patients, and 12 days (7–13) for those without aforementioned experience. The disease onset dates are earliest for Wuhan patients and latest for those without exposure to Wuhan patients. Blood lymphocytes were lowest in Wuhan patients, lower in those affected by Wuhan patients, and modest reduced in remaining ones. Disease severity is worst for Wuhan patients, and modest for those without contact with Wuhan patients. Wuhan patients had longest (27 days, 18–28), those transmitted by Wuhan patients had intermediate (16 days, 8–23), and the rest of the patients had shortest (13 days, 8.5–22.5) hospital stay. Early viral exposure, older age, lymphocytopenia, and underlying conditions are risk factors which warrant aggressive intervention. Even though the virulence of SARS-CoV-2 appears decline over the course of serial transmissions, viral testing, contact tracing, social distancing, and face masking should be imposed on general public to contain viral dissemination from both symptomatic and asymptomatic patients with this highly contagious disease.Yinjie GaoXuemei MaJingfeng BiJindong ChuBo LiuChunsheng ChiJianguo YanXiaoli YuFangming LiuXiaohong DengHongbing ZhangBo JinTaylor & Francis Grouparticlecoronavirussars-cov-2covid-19incubation periodpandemicvirulenceInfectious and parasitic diseasesRC109-216ENVirulence, Vol 11, Iss 1, Pp 1015-1023 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
coronavirus sars-cov-2 covid-19 incubation period pandemic virulence Infectious and parasitic diseases RC109-216 |
spellingShingle |
coronavirus sars-cov-2 covid-19 incubation period pandemic virulence Infectious and parasitic diseases RC109-216 Yinjie Gao Xuemei Ma Jingfeng Bi Jindong Chu Bo Liu Chunsheng Chi Jianguo Yan Xiaoli Yu Fangming Liu Xiaohong Deng Hongbing Zhang Bo Jin Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
description |
Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread from the early epicenter, Wuhan, to the rest of China, the virulence of SARS-CoV-2 might have evolved at different phases of the pandemic. We therefore compared the unique features among 62 coronavirus disease 2019 (COVID-19) inpatients who contracted SARS-CoV-2 in Wuhan (15 cases), exposed to the patients from Wuhan (26 cases), or acquired the disease without exposure to Wuhan patients (21 cases). Median incubation periods are 4.5 days (3–5) for Wuhan patients, 8 days (3–11) for those infected by Wuhan patients, and 12 days (7–13) for those without aforementioned experience. The disease onset dates are earliest for Wuhan patients and latest for those without exposure to Wuhan patients. Blood lymphocytes were lowest in Wuhan patients, lower in those affected by Wuhan patients, and modest reduced in remaining ones. Disease severity is worst for Wuhan patients, and modest for those without contact with Wuhan patients. Wuhan patients had longest (27 days, 18–28), those transmitted by Wuhan patients had intermediate (16 days, 8–23), and the rest of the patients had shortest (13 days, 8.5–22.5) hospital stay. Early viral exposure, older age, lymphocytopenia, and underlying conditions are risk factors which warrant aggressive intervention. Even though the virulence of SARS-CoV-2 appears decline over the course of serial transmissions, viral testing, contact tracing, social distancing, and face masking should be imposed on general public to contain viral dissemination from both symptomatic and asymptomatic patients with this highly contagious disease. |
format |
article |
author |
Yinjie Gao Xuemei Ma Jingfeng Bi Jindong Chu Bo Liu Chunsheng Chi Jianguo Yan Xiaoli Yu Fangming Liu Xiaohong Deng Hongbing Zhang Bo Jin |
author_facet |
Yinjie Gao Xuemei Ma Jingfeng Bi Jindong Chu Bo Liu Chunsheng Chi Jianguo Yan Xiaoli Yu Fangming Liu Xiaohong Deng Hongbing Zhang Bo Jin |
author_sort |
Yinjie Gao |
title |
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
title_short |
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
title_full |
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
title_fullStr |
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
title_full_unstemmed |
Epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
title_sort |
epidemiological and clinical differences of coronavirus disease 2019 patients with distinct viral exposure history |
publisher |
Taylor & Francis Group |
publishDate |
2020 |
url |
https://doaj.org/article/0dea6c10186f428eb2dce132e7933820 |
work_keys_str_mv |
AT yinjiegao epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT xuemeima epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT jingfengbi epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT jindongchu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT boliu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT chunshengchi epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT jianguoyan epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT xiaoliyu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT fangmingliu epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT xiaohongdeng epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT hongbingzhang epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory AT bojin epidemiologicalandclinicaldifferencesofcoronavirusdisease2019patientswithdistinctviralexposurehistory |
_version_ |
1718425462566289408 |